After our two successful editions, we are glad to announce the 3^rd Annual Epigenetics Discovery Congress.

With a tremendous progress in technology to generate and analyze reference epigenomes, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas.  Additionally, novel epigenetic molecules across many target classes for drug discovery, have been the prime focus of the pharmaceutical industry.

To meet and support this pace of the epigenetics research and development field, the 3^rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.

Speakers:

Paola Arimondo, ETaC, France

Roland Baumgartner, 4SC, Germany 

Carlos Buesa, Oryzon, Spain

Susan Clark, Garvan Institute of Medical Research, Sydney, Australia

Jerome Dejardin, MSH, France

James Flanagan, Imperial College London, UK

Petra Hajkova, MRC Institute of Medical Sciences (LMS), UK

John Holloway, University of Southampton, UK

Kilian Huber, University of Oxford, UK

Paul Hurd, Queen Mary University of London, UK

Karen Lillycrop, University of Southampton, UK

Gavin Kelsey, The Babraham Institute, UK

Guro Lind, University of Oslo, Norway

Jelena Mann, Newcastle University, UK

Rab Prinjha, GlaxoSmithKline, UK

Joëlle Rüegg, Karolinska Institutet, Sweden

Christopher Schofield, University of Oxford, UK

Paul Shiels, University of Glasgow, UK

Jesse Smith, Epizyme, USA

Rémi Terranova, Novartis Institutes for BioMedical Research, Switzerland

Maria Toledo, University of Nottingham, United Kingdom

Jonathan Turner, Luxembourg Institute of Health, Luxembourg

Katherine West, University of Glasgow, UK

David M. Wilson, Astrazeneca, UK